{"name":"Curemark","slug":"curemark","ticker":"","exchange":"","domain":"","description":"","hq":"","founded":0,"employees":"","ceo":"","sector":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[{"name":"Other","slug":"other","revenue":0,"percentOfTotal":0,"drugCount":1,"colorKey":"oncology","drugs":[{"name":"CM-AT","genericName":"CM-AT","slug":"cm-at","indication":"Autism spectrum disorder with gastrointestinal dysfunction","status":"phase_3"}]}],"pipeline":[{"name":"CM-AT","genericName":"CM-AT","slug":"cm-at","phase":"phase_3","mechanism":"CM-AT is a serine protease that breaks down extracellular proteins to improve protein digestion and absorption in patients with autism spectrum disorder.","indications":["Autism spectrum disorder with gastrointestinal dysfunction"],"catalyst":""}],"recentEvents":[],"realNews":[{"url":"https://news.google.com/rss/articles/CBMimAFBVV95cUxOMDc5OEVINlpvbXJRTGVTcWEwal9BNGRBZ2Ywei1QbmlQUzM0SnJzREtYZG9HcHltUkN6OFpoZFc3U0x2TVJBUGhJOVZIU3IwZF9lR0M0RW05WFp6N3I0amt5S3BITE5vVTBhY0ZwUm5GOHRxd2kxU3d4TnRWVlc4cHFKTm9abzF5VDVDc2JXUDBfRUlEb2paSA?oc=5","date":"2025-11-28","type":"trial","source":"Clinical Trials Arena","summary":"7MM autism spectrum disorder market to reach $2bn by 2034 - Clinical Trials Arena","headline":"7MM autism spectrum disorder market to reach $2bn by 2034","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMilAFBVV95cUxOWEtqZUN0clh5aTQta2QzTk5mQUduZ29MZ3NneVZBSl81bm1FeUdGQmhCTVY1TG9Ec1JXOWtDZlF6VERUUFN0LW9NQVY0TEJRMVV6MTVIZDNIX0V3ck1yc2pZNXFseF91YTBMUm1xSVpkT2NGS215akkyNkp3cXgyZUh5V1A1dlFoZEN3SDhxWG9sNTA5?oc=5","date":"2025-07-23","type":"regulatory","source":"Yahoo Finance","summary":"Autism Spectrum Disorder Therapeutics Market Forecast Report 2025-2034 | Rising Number of Pipeline Drugs and Growth in Clinical Trials to Meet Rising Demand Fueling Growth - Yahoo Finance","headline":"Autism Spectrum Disorder Therapeutics Market Forecast Report 2025-2034 | Rising Number of Pipeline Drugs and Growth in C","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMigAFBVV95cUxORXJMZ2g5dDZRY1hqYmNPamNaTDltdXZFWnQyWnZqakw4eUFuTFR1WGJ5LVh2SlR2eWRMU18zT2lJLWxuU0ZmNmZueHo0UGJ4ZzJJWklmbUdCd0ZRZ0VjV1FoSS1KbW5PaFZFUVh1T0JoNEtYR1IxeGhJTExBSFNQYw?oc=5","date":"2024-04-25","type":"pipeline","source":"BioSpace","summary":"As Autism Cases Rise, Biopharma Springs Into Action - BioSpace","headline":"As Autism Cases Rise, Biopharma Springs Into Action","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMizwFBVV95cUxPUWo3WTFRUG82dTk1MVhiVGl6S1ZvLURFektJblZNcldzblN4VjM5T2hDYmVyQzRrQnpLT2hLQUdKRW5Cd1ZINzA5YXRmcWlIblBoZUQ2Q0x4MFlqWEMxNmo4S3FIcmg0SXVkenp5ZUxWNmoyRU44SW1mN2cyLVBRVlRDT1U3cnE0TFkteTlRMTJuOFhCTmc3bjdXaFNlWkh1eXg1Q1Q2cHVQQ2R3QWxzM1JuLXVEWndJSmV1d000Mnd0UmthLXdEWlRaY2xETlE?oc=5","date":"2023-12-04","type":"regulatory","source":"BioSpace","summary":"JAMA Publishes Article Showing Long-Term Improvement in Autism with Curemark's Pancreatic Replacement Therapy - BioSpace","headline":"JAMA Publishes Article Showing Long-Term Improvement in Autism with Curemark's Pancreatic Replacement Therapy","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiywFBVV95cUxQdUZYMnJJbHhXbHRaRHpIM3UtM2lMUkd5akJVbVoxVVhDTV8wOTAtcTE1Ym5CZmF0Q0IwaHpmb2VrRldvaFVjQk9pZThTOGJiWXdudTJBZlN5NXU3RGNtTXA3T3REd3lUNmJ2ZXhTdzZYNENGTjd1RkJIRGt4eU40LXhIcWpnaTNvLXNrN25SRV90NEctTVdIMm9La3hOeUdVZ1Q1cW1BVk8zZENZdGcxa2JTMFZoZTZuOG5iVk5LUGUwTzhfcE1XVnM3MA?oc=5","date":"2021-01-10","type":"regulatory","source":"Medium","summary":"Dr Joan Fallon of Curemark: 5 Things I Wish Someone Told Me Before I Became A CEO - Medium","headline":"Dr Joan Fallon of Curemark: 5 Things I Wish Someone Told Me Before I Became A CEO","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMinwFBVV95cUxNN0tMQWZTNk5mTERnaDR5NFNVcmhVaUk2dEhmTm9VRXlwNWluR0JnbG8zc0xDYTlzVVpGWnNzMG1Ba09yOVdDUlhPN0F1UGFDVGFUd1Q3MGhBVXJqMHEwSW02MU1ya0tPRlUwbXdEbnJVUVY5QmhJWUtsQ3dnVFpKb0MwbUprZGZLZFBwdk11dEJqT2NvQ2NYbWswZFBBaXPSAacBQVVfeXFMUHJIMldGT2pmQTZSazluN3YtVG9jN3RLbFdJcWpnTk03T1ZlcGp0ODB1U2Y1VlktWUpiZURpSmVncWZzQ1hkVk5jX1p1dXJtUklsUUozUU0tNEpQdDFoUmN2TWIwTkQ0aURiZ2d6X3ZqeHZuTFlOdFU1WlVBN0tlSzVHTHZURkJjbzd4VUpLYnI0dnR4WlpKS3lLaGtSNnotWGpWM293NGM?oc=5","date":"2014-02-21","type":"pipeline","source":"Westchester Magazine","summary":"Biotech Guide: A List of Westchester’s Biotech Companies - Westchester Magazine","headline":"Biotech Guide: A List of Westchester’s Biotech Companies","sentiment":"neutral"}],"patents":[],"drugCount":1,"phaseCounts":{"phase_3":1},"enrichmentLevel":0,"visitCount":1,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}